Skip to main content
. Author manuscript; available in PMC: 2010 May 15.
Published in final edited form as: Biol Psychiatry. 2009 Feb 28;65(10):857–862. doi: 10.1016/j.biopsych.2009.01.018

Figure 3.

Figure 3

VTA perfusion of α-helical CRF (1 μM), an antagonist at CRF receptors, had no effect on VTA Hcrt-1-induced reinstatement of cocaine-seeking or on VTA dopamine or glutamate levels. * indicate difference from the non-Hcrt-1 conditions.